EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Enhanced Efficacy of Thalidomide‐Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi‐Center Cohort Study

Jinzhi Xu iD, Li Song, Yifan Kong, Jie Li, Jian Zhang, Tao Ye, Yongqiang Liu, Xin Yin, Biwei Yang, Zhiying Zhao, Peixin Huang, Yi Chen und 6 weitere

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71116 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift MedComm, online erschienen am 31.10.2026. Verfasst von Jinzhi Xu und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Center and National Clinical Research Center for Interventional Medicine, Liver Cancer Institute, Zhongshan Hospital Fudan Universit…. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study was designed to evaluate the safety and efficacy of adding a thalidomide‐based cocktail (the TCC cocktail—comprising thalidomide, carmofur, and compound mylabris capsule) to transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC) in real‐world practice. Data from 433 unresectable HCC patients treated with TACE at four hospitals were collected (from March 2014 to May 2018, followed up to July 2023) and overall survival (OS), overall response rate (ORR), disease control rate (DCR), and adverse events (AEs) were analyzed. After 1: 2 propensity score matching (PSM), 114 patients in the cocktail group (TACE + TCC) were compared with 228 patients in the control group (TACE alone). The median OS of the cocktail group was significantly better than that of the control group ( p < 0.001; 42.5 vs. 12.5 months) after PSM. ORR (29.8% vs. 21.1%, p = 0.081) and DCR (79.8% vs. 61.8%, p < 0.001) at 6 months were also better in the cocktail group after PSM. Moreover, no life‐threatening AEs (grade 4 or 5) occurred in either group. In this retrospective cohort, the addition of the TCC cocktail to TACE was associated with improved survival and tumor response, with a manageable safety profile.

Schlagwörter

Stichwörter der Autor:innen

TCC cocktailhepatocellular carcinoma (HCC)metronomic chemotherapytransarterial chemoembolization (TACE)uracil analogues

Autor:innen und Institutionen

  • National Medical Center and National Clinical Research Center for Interventional Medicine, Liver Cancer Institute, Zhongshan Hospital Fudan University Shanghai China.
  • Department of Hematology, Shanghai Geriatric Medical Center Zhongshan Hospital Fudan University Minhang Campus Shanghai China.
  • Department of Infectious Diseases Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China.
  • Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation The First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang China.
  • Department of Oncology Minhang Hospital Fudan University Shanghai China.
  • Department of Radiology Kecheng People's Hospital Quzhou Zhejiang China.

ORCID-Profile: Jinzhi Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, J., Song, L., Kong, Y., Li, J., Zhang, J., Ye, T., Liu, Y., Yin, X., Yang, B., Zhao, Z., Huang, P., Chen, Y., Jiang, M., Ge, N., Wali, F., Hu, W., Zhu, G., & Xia, J. (2026). Enhanced Efficacy of Thalidomide‐Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi‐Center Cohort Study. MedComm, 7(11). https://doi.org/10.1002/mco2.71116

Vancouver

Xu J, Song L, Kong Y, Li J, Zhang J, Ye T, et al. Enhanced Efficacy of Thalidomide‐Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi‐Center Cohort Study. MedComm. 2026;7(11). doi:10.1002/mco2.71116

BibTeX
@article{Xu2026,
  author = {Xu, Jinzhi and Song, Li and Kong, Yifan and Li, Jie and Zhang, Jian and Ye, Tao and Liu, Yongqiang and Yin, Xin and Yang, Biwei and Zhao, Zhiying and Huang, Peixin and Chen, Yi and Jiang, Matteo and Ge, Ningling and Wali, Faiz and Hu, Wenhao and Zhu, Guoqing and Xia, Jinglin},
  title = {Enhanced Efficacy of Thalidomide‐Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi‐Center Cohort Study},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71116}
}
Kostenlos starten →